Shopping Cart
- Remove All
- Your shopping cart is currently empty
Mosnodenvir (JNJ-1802) is a pan-DENV inhibitor effective against all four serotypes of dengue viruses, with the advantage of being highly potent and orally bioavailable, and blocks viral replication by inhibiting the formation of the complex between NS3 and NS4B.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $154 | In Stock | |
5 mg | $325 | In Stock | |
10 mg | $513 | In Stock | |
25 mg | $872 | In Stock | |
50 mg | $1,310 | In Stock | |
100 mg | $1,960 | In Stock | |
1 mL x 10 mM (in DMSO) | $416 | In Stock |
Description | Mosnodenvir (JNJ-1802) is a pan-DENV inhibitor effective against all four serotypes of dengue viruses, with the advantage of being highly potent and orally bioavailable, and blocks viral replication by inhibiting the formation of the complex between NS3 and NS4B. |
Targets&IC50 | SARS-CoV-2 XBB:0.43 μM (EC₅₀), SARS-CoV-2 BA.5:0.27 μM (EC₅₀) |
In vitro | Mosnodenvir inhibited SARS-CoV-2 BA.5 and XBB in Vero E6 cells with EC₅₀ values of 0.27 μM and 0.43 μM, respectively, and showed broad-spectrum antiviral activity in other cell lines[1]. |
In vivo | In hACE2 transgenic mice, Mosnodenvir (200 mg/kg, i.p., daily × 5 days) reduced lung viral titers by >99% and alleviated lung damage, with good oral bioavailability (>80%)[1]. |
Alias | JNJ-1802, JNJ 64281802 |
Molecular Weight | 582.98 |
Formula | C26H22ClF3N2O6S |
Cas No. | 2043343-94-6 |
Smiles | C(C(NC1=CC(S(C)(=O)=O)=CC(OC)=C1)C2=C(OC)C=C(Cl)C=C2)(=O)C=3C=4C(NC3)=CC=C(OC(F)(F)F)C4 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.